Frontiers in Cardiovascular Medicine | Cardiovascular Metabolism

Clinical Trial

Published on 25 Jan 2023

The effects of pemafibrate and omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, parallel group trial in Japan (PROUD48 study)

in Cardiovascular Metabolism

Yasutaka Takeda
Ichiro Sakuma
Shinya Hiramitsu
Mizuho Okada
Shinichiro Ueda
Masaru Sakurai

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1094100

4,462 views
6 citations

Original Research

Published on 24 Jan 2023

Role of mitochondrial metabolism in immune checkpoint inhibitors-related myocarditis

in Cardiovascular Metabolism

Xin Zhang
Yi Gan
Haoshuai Zhu
Zhihao Liu
Xiaojing Yao
Chao Cheng
Zhenguo Liu
Chunhua Su
Jianyong Zou

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1112222

2,367 views
3 citations

Original Research

Published on 18 Jan 2023

A small erythropoietin derived non-hematopoietic peptide reduces cardiac inflammation, attenuates age associated declines in heart function and prolongs healthspan

in Cardiovascular Metabolism

Nolan M. Winicki
Alay P. Nanavati
Christopher H. Morrell
Jack M. Moen
Jessie E. Axsom
Melissa Krawczyk
Natalia N. Petrashevskaya
Max G. Beyman
Christopher Ramirez
Irene Alfaras

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.1096887

3,949 views
2 citations

Original Research

Published on 18 Jan 2023

Energy metabolism disorder dictates chronic hypoxia damage in heart defect with tetralogy of fallot

in Cardiovascular Metabolism

Libao Liu
Lei Huang
Lishuai Yao
Fan Zou
Jinyuan He
Xiaodong Zhao
Lugang Mei
Shuai Huang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.1096664

2,778 views
2 citations

Review

Published on 12 Jan 2023

Effects of treatment of non-alcoholic fatty liver disease on heart failure with preserved ejection fraction

in Cardiovascular Metabolism

Zifeng Yang
Ruifeng Tian
Xiao-Jing Zhang
Jingjing Cai
Zhi-Gang She
Hongliang Li

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.1120085

6,284 views
8 citations

Original Research

Published on 09 Jan 2023

Proteome-wide analysis of lysine β-hydroxybutyrylation in the myocardium of diabetic rat model with cardiomyopathy

in Cardiovascular Metabolism

Weiguang Luo
Mei He
Qizhi Luo
Yi Li

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.1066822

3,376 views
6 citations

Original Research

Published on 05 Jan 2023

Single-cell transcriptomes and T cell receptors of vaccine-expanded apolipoprotein B-specific T cells

in Cardiovascular Metabolism

Felix Sebastian Nettersheim
Yanal Ghosheh
Holger Winkels
Kouji Kobiyama
Christopher Durant
Sujit Silas Armstrong
Simon Brunel
Payel Roy
Thamotharampillai Dileepan
Marc K. Jenkins

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.1076808

6,473 views
4 citations

Editorial

Published on 16 Dec 2022

Editorial: Metabolic hormones and inflammation

in Cardiovascular Metabolism

Matthew C. Gage
Fawaz Alzaid
Alison Delamere McNeilly
Edward A. Fisher

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.1102900

1,499 views
1 citation

Review

Published on 14 Dec 2022

The role of mitochondria-associated membranes mediated ROS on NLRP3 inflammasome in cardiovascular diseases

in Cardiovascular Metabolism

Jiahao Zhao
Junli Li
Guoyong Li
Mao Chen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.1059576

6,167 views
23 citations

Editorial

Published on 05 Dec 2022

Editorial: Human microbiota: A key player in the etiology and pathophysiology of cardiovascular and metabolic diseases

in Cardiovascular Metabolism

Ganesan Velmurugan
Tharmarajan Ramprasath
Gilles Mithieux

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.1081722

1,050 views
1 citation

Review

Published on 24 Nov 2022

Metabolic remodeling in takotsubo syndrome

in Cardiovascular Metabolism

Ti Wang
Ting Xiong
Yuxue Yang
Bangyun Zuo
Xiwei Chen
Daxin Wang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.1060070

3,571 views
6 citations

Original Research

Published on 14 Nov 2022

Circulating homocysteine and folate concentrations and risk of type 2 diabetes: A retrospective observational study in Chinese adults and a Mendelian randomization analysis

in Cardiovascular Metabolism

Yating Cheng
Chen Wang
Xiaokang Zhang
Yue Zhao
Bingyu Jin
Chunfang Wang
Zhibing Lu
Fang Zheng

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.978998

3,511 views
3 citations

Mini Review

Published on 10 Nov 2022

Emerging roles of fibroblast growth factor 21 in critical disease

in Cardiovascular Metabolism

Fang Yan
Li Yuan
Fan Yang
Guicheng Wu
Xiaobo Jiang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.1053997

4,291 views
8 citations

Original Research

Published on 07 Nov 2022

Short sleep duration associated with increased risk for new-onset cardiovascular diseases in individuals with metabolic syndromes: Evidence from the China Health and Retirement Longitudinal Study

in Cardiovascular Metabolism

Jiaxin Sun
Yizhou Chen
Yazhou Sun
Bo Yang
Jining Zhou

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.1010941

2,504 views
1 citation

Original Research

Published on 07 Nov 2022

PERM1 regulates energy metabolism in the heart via ERRα/PGC−1α axis

in Cardiovascular Metabolism

Shin-ichi Oka
Karthi Sreedevi
Thirupura S. Shankar
Shreya Yedla
Sumaita Arowa
Amina James
Kathryn G. Stone
Katia Olmos
Amira D. Sabry
Amanda Horiuchi

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.1033457

6,191 views
14 citations

Systematic Review

Published on 04 Nov 2022

Mapping current research and identifying hotspots of ferroptosis in cardiovascular diseases

in Cardiovascular Metabolism

Teng Teng
Chun-Yan Kong
Rong Huang
Zhen-Guo Ma
Can Hu
Xin Zhang
Min Hu
Qi-Zhu Tang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.1046377

5,341 views
7 citations

Navigation group

Articles

The effects of pemafibrate and omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, parallel group trial in Japan (PROUD48 study)

Role of mitochondrial metabolism in immune checkpoint inhibitors-related myocarditis

A small erythropoietin derived non-hematopoietic peptide reduces cardiac inflammation, attenuates age associated declines in heart function and prolongs healthspan

Energy metabolism disorder dictates chronic hypoxia damage in heart defect with tetralogy of fallot

Effects of treatment of non-alcoholic fatty liver disease on heart failure with preserved ejection fraction

Proteome-wide analysis of lysine β-hydroxybutyrylation in the myocardium of diabetic rat model with cardiomyopathy

Single-cell transcriptomes and T cell receptors of vaccine-expanded apolipoprotein B-specific T cells

Editorial: Metabolic hormones and inflammation

The role of mitochondria-associated membranes mediated ROS on NLRP3 inflammasome in cardiovascular diseases

Editorial: Human microbiota: A key player in the etiology and pathophysiology of cardiovascular and metabolic diseases

Metabolic remodeling in takotsubo syndrome

Circulating homocysteine and folate concentrations and risk of type 2 diabetes: A retrospective observational study in Chinese adults and a Mendelian randomization analysis

Emerging roles of fibroblast growth factor 21 in critical disease

Short sleep duration associated with increased risk for new-onset cardiovascular diseases in individuals with metabolic syndromes: Evidence from the China Health and Retirement Longitudinal Study

PERM1 regulates energy metabolism in the heart via ERRα/PGC−1α axis

Mapping current research and identifying hotspots of ferroptosis in cardiovascular diseases